---
title: Peptide Manufacturing CDMOs in Asia-Pacific
path: /services/peptide-manufacturing/apac
companies_count: 14
---

# Peptide Manufacturing CDMOs in Asia-Pacific

14 published CDMOs match Peptide Manufacturing in Asia-Pacific.

Locations in this set include United States, China, India, United Kingdom, Japan, and Singapore.

Capabilities that show up most often in this set: Peptide, Small Molecule, Oligonucleotide, Antibody-Drug Conjugate (ADC), and Biologics (Other).

## Matching companies

- [Ajinomoto Bio-Pharma Services](/companies/ajibio-pharma)
  - Ajinomoto Bio-Pharma Services is a global contract development and manufacturing organization (CDMO) dedicated to improving the health of humankind through adaptive solutions and responsive service.
- [Almac Group](/companies/almacgroup)
  - Global CDMO with 7,900+ employees across 18 facilities, offering integrated drug development and manufacturing services including analytical development, formulation, process development, fill-finish, and specialized chemistry capabilities.
- [Bachem](/companies/bachem)
  - Global leader in peptide and oligonucleotide development and manufacturing, offering GMP-compliant clinical and commercial supply from early research through commercial scale.
- [DSK InnoSciences Ltd](/companies/dskinnosciences)
  - DSK InnoSciences is an established contract chemistry services company in Bangalore, India, offering synthesis, process development, and manufacturing of pharmaceuticals, specialty chemicals, and peptides from milligram to kilogram scale.
- [Divi's Laboratories](/companies/divislabs)
  - World's largest API manufacturer and trusted CDMO partner for 25+ years, offering generic APIs, custom synthesis, peptides, and nutraceutical ingredients to 100+ countries with complete backward integration and green chemistry principles.
- [Global Biotech Laboratories](/companies/globalbiotechlaboratories)
  - Global Biotech Laboratories is a peptide and oligonucleotide CDMO offering end-to-end contract development and manufacturing from route scouting through validated commercial supply, with cGMP and ICH Q7 compliance across manufacturing sites on three continents.
- [JYMed Peptide](/companies/jymedtech)
  - Peptide CDMO offering custom synthesis from milligrams to metric tons, with 13 cGMP lines and FDA-, NMPA- and EDQM-approved sites. Provides peptide API manufacturing plus syringe, cartridge and lyophilized finished-dose filling at its Shenzhen site.
- [Neuland Laboratories](/companies/neulandlabs)
  - Global API CDMO supporting biotechnology and pharmaceutical companies in design, development, and manufacturing of complex active pharmaceutical ingredients from early-stage drug development through commercial scale.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Piramal Pharma Solutions](/companies/piramalpharmasolutions)
  - CDMO specializing in HPAPIs, ADCs, peptides, vaccines, and biologics with 4,700+ team members across 15 global sites and 500+ customers. Offers integrated development and manufacturing with backward integration capabilities and global program management.
- [Porton](/companies/portonpharma)
  - Porton is a global CDMO offering integrated manufacturing and development services across small molecules, peptides, oligonucleotides, biologics, and conjugates with specialized capabilities in flow chemistry, biocatalysis, and advanced therapies.
- [SK pharmteco](/companies/skpharmteco)
  - SK pharmteco is a CDMO offering comprehensive drug development and manufacturing services.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [重庆兴泰濠制药有限公司 (Sintaho)](/companies/sintaho)
  - China-based API and CDMO/CMO supplier focused on cytotoxic and OEB5 high-potency APIs, peptides, and XDC compounds. Reports FDA on-site inspections in 2024 and 2025 and product registrations in more than 30 countries.